Research output per year
Research output per year
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Comparison of critical quality attributes of therapeutic monoclonal antibodies from the NISTCHO cell line under varying critical process parameters
Berger, T., Schäpertöns, V. (Corresponding author), Hofer, L. (Corresponding author), Štor , J. (Corresponding author), Fortelny, N. (Corresponding author), Borth, N. (Corresponding author) & Huber, C. G. (Editor), 7 Oct 2024.Research output: Contribution to conference › Poster
-
Characterization of Antibody N-glycosylation from a Publicly Available Producer CHO Cell Line: NISTCHO
Berger, T., Rabl, J. (Corresponding author), Schäpertöns, V. (Corresponding author), Hofer, L. (Corresponding author), Štor , J. (Corresponding author), Fortelny, N. (Corresponding author), Borth, N. (Corresponding author) & Huber, C. G. (Editor), 25 Jun 2024.Research output: Contribution to conference › Poster
-
Characterization of critical quality attributes of therapeutic monoclonal antibodies from different CHO cell line subclones – a case study
Berger, T., Schäpertöns, V. (Corresponding author), Borth, N. & Huber, C. G. (Editor), 23 Feb 2024.Research output: Contribution to conference › Abstract
-
Characterization of critical quality attributes of therapeutic monoclonal antibodies
Berger, T., Paunovic, A., Schäpertöns, V., Böttinger, K., Kozma, B., Herwig, C. & Huber, C. G., 26 Sept 2023.Research output: Contribution to conference › Poster
-
Comparison of Critical Quality Attributes of Therapeutic Monoclonal Antibodies from the NISTCHO Cell Line under Varying Critical Process Parameters
Berger, T. (Speaker)
7 Oct 2024Activity: Talk or presentation › Poster presentation › science to science / art to art
-
Characterization of Antibody N-glycosylation from a Publicly Available Producer CHO Cell Line: NISTCHO
Berger, T. (Speaker)
25 Jun 2024Activity: Talk or presentation › Poster presentation › science to science / art to art
-
Characterization of critical quality attributes of therapeutic monoclonal antibodies from different CHO cell line subclones – a case study
Berger, T. (Speaker)
23 Feb 2024Activity: Talk or presentation › Oral presentation › science to science / art to art
-
Characterization of critical quality attributes of therapeutic monoclonal antibodies
Berger, T. (Speaker)
26 Sept 2023Activity: Talk or presentation › Poster presentation › science to science / art to art